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Oral lichen planus (OLP) represents a common mucocutaneous disease. Various authors 		
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in malignant transformation have not yet been elucidated. A 79-year-old man presented a 
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0.05% clobetasol ointment for treatment, the lesion became ulcerated. A new biopsy of 
the same lesion was performed, and histological analysis showed an in situ oral carcinoma 
(ISOC). An immunohistochemistry panel was performed, and p16 expression was negative 
in OLP, however, it showed weak cytoplasmic staining in ISOC. There was strong nuclear 
BUB3 staining in both OLP and ISOC areas. p53 showed less intense nuclear staining in 
both regions. Ki67 was negative in OLP area, but showed nuclear staining in the ISOC. 
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malignant potential of OLP.
Keywords: Carcinoma in situ. Oral lichen planus. Oral pathology. Immunohistochemistry. 
Neoplastic cell transformation.
INTRODUCTION
Oral lichen planus (OLP) represents a common 
mucocutaneous disease that affects 0.5 to 2% of 
the population5. Malignant transformation of OLP in 
oral squamous cell carcinoma (OSCC) is possible 
according to a 10-year retrospective study, besides 
some cross-sectional and cohort studies4-6,10,29. 
However, the mechanisms involved in malignant 
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therefore, some authors do not consider that OLP 
presents this potential3.
p53 and Ki67 are current biomarkers used in 
OSCC and precursor lesions. The establishment of 
new biomarkers to predict or indicate malignant 
transformation would be very useful in the 
management of OLP patients21,22. Some genes 
and antibodies, such as p16, BUB3 and SOX4, are 
currently studied in different types of cancer in order 
to establish new possible markers. However, little 
is known about such antibodies in OSCC precursor 
lesions or conditions, especially OLP1,8,11,13,27.
This paper aims to report a case of an in situ 
oral carcinoma (ISOC) that developed on a previous 
OLP lesion in a 79-year-old man. We evaluated the 
immunohistochemical expression of Ki67, p53, p16, 
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CASE REPORT
A 79-year-old white man complained of a white 
lesion in the buccal mucosa to his dermatologist. He 
was being monitored in a medical service for older 
adults for a long time because of multiple basal cell 
skin carcinomas previously treated. The patient had 
hypertension treated with captopril and indapamide. 
He denied smoking and alcoholism. The remaining 
medical history was not relevant.
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Figure 1- Clinical aspect of the right buccal mucosa: ulcer with an erythematous halo and small white plaques in the center 
of the picture
Figure 2-	
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lichenoid area; b) Carcinoma in situ showing several changes from basal layer to upper layer of epithelium. The following 
alterations are present: cells with enlarged nuclei, pleomorphic cells, hyperchromatism, increased nuclear-to-cytoplasmic 
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An incisional biopsy of the buccal lesion was 
conducted by the dermatologist at the right 
buccal mucosa. Five months after such procedure, 
the patient became symptomatic, and some 
erythematous areas appeared mixed with white 
areas. At that time, the diagnosis of OLP was 
established by the dermatologist who prescribed 
0.05% clobetasol ointment. After two months 
without lesion remission, the patient was referred 
to an oral and maxillofacial surgeon, who found an 
ulcer with an erythematous halo and some small 
white plaques around in the right buccal mucosa 
(Figure 1). Some smaller white plaques were also 
observed on the left buccal mucosa. A new incisional 
biopsy was performed by the oral surgeon at the 
same area of the right-sided lesion, previously 
diagnosed as OLP.
Histological examination revealed pleomorphic 
epithelial cells with hyperchromatic nuclei and 
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subjacent connective tissue was not involved. These 
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(ISOC). Furthermore, adjacent to the ISOC area, 
the epithelium showed hyperkeratosis, angulated 
rete pegs and basal cell liquefaction. Extensive 
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were consistent with the previous diagnosis of OLP. 
Histological aspects are shown in Figure 2.
An immunohistochemical panel with Ki67 
(BIOCARE, SP6, 1:100), p53 (DAKO, Clone DO-7, 
1:200), p16 INK4a (Pharmingen, Clone G175-
405 BD, 1:200), SOX4 and BUB3 (ABCAM, Clone 
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(Figure 3). p16 was positive both in the area of 
OLP as the ISOC, with cytoplasmic and nuclear 
staining in the basal and suprabasal layers. BUB3 
showed nuclear staining in more than 90% of cells 
in both studied areas. p53 showed less than 10% 
nuclear staining in the OLP and less than 20% in 
the ISOC. SOX4 was negative in both studied areas. 
Ki67 showed from 20 to 30% of positive cells only 
in the ISOC area. The antibodies data are shown 
in Table 1.
The lesion was resected with safe surgical 
margins. Histological examination revealed some 
areas compatible with ISOC, some compatible with 
epithelial dysplasia (moderate to severe), and also 
one area close to the lateral limit of the specimen 
Figure 3- Immunohistochemistry (400X): p16 nuclear and cytoplasmic staining basal and suprabasal layers – oral lichen 
planus (OLP) area (a); p16 nuclear and cytoplasmic staining basal and suprabasal layers – in situ oral carcinoma (ISOC) 
area (b); BUB3 nuclear staining - OLP area (c); BUB3 nuclear staining - ISOC area (d); p53 nuclear staining - OLP area 
(e); p53 nuclear staining - ISOC area (f); Ki67 negative - OLP area (g); Ki67 nuclear staining basal and suprabasal layers 
- ISOC area (h)
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compatible with OLP. No signs of microinvasion were 
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had scarring in the buccal mucosa, but no signs of 
recurrence were observed. No syndrome associated 
with basal cell carcinoma was detected.
DISCUSSION
OLP can manifest as whitish striations or plaques, 
atrophic erythematous areas, ulcers, papules and 
vesicles. Three morphological types are usually 
described: the reticular form - asymptomatic 
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form - reddish areas alone or between whitish 
striations, and the erosive form - painful ulcerations 
added to the other features. The predominant 
morphology can change over time. The present case 
is compatible with the erosive form that has the 
highest probability of malignant transformation4,8. 
However, lichenoid reaction to captopril could also 
be considered, which represents a limitation in the 
present case.
In a prospective study conducted with 327 OLP 
patients, eight of them (2.4%) developed OSCC4. 
Although the sample had 229 women and only 98 
men, the rate of transformation of OLP to OSCC was 
higher in men (3%) than in women (2.1%). The 
mean age in patients who developed OSCC was 68 
years in women and 62 years in men, both higher 
than the overall group4. Our patient was even older 
than the female median in comparison with this 
group. Moreover, some authors indicate that that 
OLP can evolve both in squamous cell carcinoma 
and, possibly, oral melanoma.
Timing for carcinoma appearance in preexisting 
OLP in the same study varied from 2.68 to 3.26 
years 4. However, time between OLP diagnosis and 
development of malignancy in the current case 
was only seven months. It is possible that OLP was 
already present for much longer as a reticular form 
without symptoms.
The patient was being monitored in a medical 
service for older adults for a long time before 
complaining of mouth problems. Nevertheless, he 
was only referred to the dentist after an attempt 
to treat the oral problems. We consider that the 
mouth exam should be performed preemptively 
by a dentist, aiming to achieve early diagnosis and 
avoid complications. A large study conducted with 
3142 patients found that 1% had oral potentially 
malignant disorders, among them 9 cases of 
OLP26. The importance of oral analysis and tactile 
examination in earlier diagnosis of oral mucosal 
diseases was emphasized.
In situ carcinoma developed over oral lichen planus: a case report with analysis of BUB3, p16, p53, Ki67 and SOX4 expression
Antibodie OLP ISOC 
P16 INK4a Clone G175-405 BD 
Pharmingen 
(+) (+)
1:200 Weak and Focal Weak and Focal
Cytoplasmatic Cytoplasmatic
Basal layer Basal layer
BUB 3 Clone EPR5319(2) (+) (+)
1:500 ABCAM Strong  (> 90%) Strong  (> 90%)
Nuclear Nuclear
Basal, espinous and 
granular layers.
Basal, espinous and 
granular layers.
P 53 Clone DO-7 (+) (+)
1:200 DAKO Weak  <10% Weak < 20%
Nuclear Nuclear
Basal layer Basal and spinous layers
SOX 4 Policlonal (-) (-)
1:800 ABCAM
Ki67 Clone SP6 (-) (+)
1:100 BIOCARE Strong  20 a 30%
Nuclear
Basal and spinous layers
Table 1- Immunohistochemical panel
OLP= oral lichen planus; ISOC= in situ oral carcinoma
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Multiple basal cell carcinomas may be a 
component of several syndromes such as Gorlin-
Goltz20. No keratocysts or other phenotypes of this 
syndrome were detected by the dental team. In the 
same way, no other syndromes were detected by 
the dermatologists in the previous exam.
Higher expression of Ki67 and p53 in OLP 
compared with normal oral mucosa was previously 
observed, which may favor the malignant potential 
of OLP2. p53 is an important tumor suppressor 
gene related to oral carcinogenesis. Its mutations 
have been detected in OLP and OSCC among 
other lesions, and may be related to malignancy 
development18,19,25. In the present case, although 
weak, there was p53 marking in both ISOC and 
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associated with the OLP. Ki67 antibody is widely 
used to assess cellular proliferation in cancer and 
cancer precursor lesions including oral lesions21,22. 
There was no considerable expression of Ki67 in the 
OLP area, different from what was observed in some 
previous studies, in which the expression ranged 
from 13 to 20%2,15,30. This suggests that some 
cases of OLP may present a potential for malignant 
transformation independent of Ki67 expression.
p16 is an INK4a family member with a role in cell 
cycle regulation. Its function leads to inhibition of Rb 
phosphorylation, arresting cell cycle17. Suppression 
of p16 expression appears to represent an initial 
event in oral carcinomas development9. However, 
similar to cervical intraepithelial neoplasia and 
cervical cancer, p16 overexpression was also found 
in OSCC1,9. The HPV inhibition of Rb protein leads to 
high p16 levels, due to negative feedback regulation 
in cervical lesions. Thus, p16 is considered a useful 
biomarker for cervical cancer7.
p16 expression in OLP was evaluated in three 
previous studies, with positivity index ranging from 
26.7 to 65.2%23,24. However, the criteria used in 
each study was very different (p16 expression 
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Normal mucosa and OSCC were p16 negative16. In 
the present case, the p16 expression was found in 
focal areas, both in OLP and ISOC. This expression, 
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malignant potential of OLP or simply suggest the 
presence of HPV in OLP. More studies are needed 
to elucidate the relationship between OLP and p16.
Numerous cell cycle regulatory molecules have 
been studied recently. BUB3 has an important role 
in stabilizing the spindle assembly checkpoint. Some 
studies using different molecular biology techniques 
have correlated deregulation of BUB3 expression 
in different types of cancer8. The low expression 
of BUB3 can lead to abnormal chromosome 
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to appear12. However, overexpression of BUB3 gene 
was also correlated with high expression of Ki67 in 
gastric cancer11.
In a similar pattern, an intense epithelial 
expression of BUB3 was detected in the present 
case, indicating that BUB3 may behave in the 
same way in oral cancer and precursor lesions 
as OLP. Since this is a pioneer report of BUB3 
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that hypothesis.
SOX4 is a molecule involved in DNA transcription 
and regulation of apoptosis. Increased expression 
of SOX4 has been detected in malignant tumors 
of breast, lung, colon and salivary glands, among 
others14. A study with 50 cases of OSCC showed 
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of SOX4 and tumor staging28. The expression of 
SOX4 in poorly differentiated OSCC was higher 
than that observed in well-differentiated tumors. 
Furthermore, a high expression of SOX4 in lymph 
node metastases was also observed. The authors 
suggested that SOX4 may have a role in the 
differentiation of oral cancer. However, SOX4 was 
negative in the present case. There are no studies 
evaluating the immunohistochemical expression of 
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CONCLUSION
The present case supports the malignant 
potential of OLP through the clinical course. In 
addition, the pattern of Ki67 (absent) and p53 
(weak) expression in OLP areas suggest that even 
in presence of typical histological appearance, 
OLP can undergo malignant transformation. These 
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diagnosis and continuous monitoring of OLP lesions, 
/

#$#&'

reported in the present case, and p16 may suggest 
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or the malignant potential of OLP. More detailed 
studies should be performed to investigate such 
hypotheses.
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